Search a show

Search a show

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Podcast AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast

American Geriatrics Society

Health & Fitness

Frequency: 1 episode/9d. Total Eps: 8

Hosting podcast Buzzsprout

This podcast is part of a larger online curriculum from the American Geriatrics Society developed to educate health professionals on the rapidly evolving landscape of Alzheimer’s Disease diagnosis and treatment. Each episode features a conversation between G. Michael Harper, MD, Editor-in-Chief of the AGS Alzheimer’s Disease Curriculum, and curriculum authors. Be sure to listen as they discuss topics including pathology and diagnosis, the role of neuroimaging, recent advances in amyloid-targeted therapies and monoclonal antibody treatments, discussions strategies to use with patients and families, and how to ensure equitable care for underrepresented populations in clinical trials. To access the full curriculum and other AGS resources, please visit: https://geriatricscareonline.org

Read moreCollapse

Site

RSS

Apple

Data updated on 14/07/2026

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

© My Podcast Data · Independent project · Data from Apple & Spotify

About Methodology Contact Support me Privacy Policy Legal Notice

Role of Fluid Biomarkers in the Diagnosis of Alzheimer’s Disease

Season 1 · Episode 8

Wednesday, December 17, 2025 • Duration 28:04

Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Cindy Carlsson , Professor of Medicine Geriatrics at the University of Wisconsin School of Medicine and Public Health and staff physician at the Madison VA Hospital Geriatric Research, Education and Clinical Center (GRECC), Madison VA Memory Assessment Clinic, as they the role of fluid biomarkers in the Diagnosis of Alzheimer’s Disease.

To view a transcript click here, then select the transcript tab.

Read moreCollapse

Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know

Season 1 · Episode 4

Friday, October 17, 2025 • Duration 26:18

Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects.

To view a transcript click here then select the transcript tab.

Read moreCollapse

The Role of Neuroimaging in Diagnosis of Alzheimer Disease

Season 1 · Episode 3

Friday, October 17, 2025 • Duration 16:58

Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Kyra O'Brien Assistant Professor of Neurology at the Hospital of the University of Pennsylvania who, co-authored the module titled The Role of Neuroimaging in Diagnosis of Alzheimer Disease along with Jason Karlawish, MD, Professor of Medicine, medical ethics and health policy, and neurology at the University of Pennsylvania Perelman School of Medicine and Co-Associate Director of the Alzheimer’s Disease Research Center, and Co-Director of the Penn Memory Center.

To view a transcript click here then select the transcript tab.

Read moreCollapse

How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)

Season 1 · Episode 6

Thursday, October 16, 2025 • Duration 32:58

Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Halima Amjad, Associate Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine and Dr. Lolita Nidadavolu, Assistant Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, as they discuss How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters).

To view a transcript click here then select the transcript tab.

Read moreCollapse

Evidence Review of FDA-Approved Monoclonal Antibody Treatments

Season 1 · Episode 5

Wednesday, October 15, 2025 • Duration 23:49

Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Eric Widera of Professor of Clinical Medicine, Division of Geriatrics at UCSF and the Director of Hospice & Palliative Care at San Francisco VA Medical Center who, co-authored the module titled Evidence Review of FDA-Approved Monoclonal Antibody Treatments along with Kaitlin Willham, MD, Outpatient Geriatrics Clinic Medical Director at the San Francisco VA and Associate Professor of Medicine, at UCSF Division of Geriatrics.

To view a transcript click here then select the transcript tab.

Read moreCollapse

Pathology and Diagnostic Frameworks for Alzheimer Disease

Season 1 · Episode 1

Wednesday, October 15, 2025 • Duration 24:00

Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Heather E. Whitson, Distinguished Professor of Neuroscience, Professor of Medicine (Geriatrics), Director of the Duke Aging Center and the Co-director of the Duke/UNC Alzheimer’s Disease Research Center, as they discuss Pathology and Diagnostic Frameworks for Alzheimer Disease.

To view a transcript click here then select the transcript tab.

Read moreCollapse

Evaluation of Cognition and Cognitive Disorder

Season 1 · Episode 2

Wednesday, October 15, 2025 • Duration 28:27

Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Esther Oh, Professor of Medicine, Psychiatry and Behavioral Sciences and Pathology at the Johns Hopkins University School of Medicine and Co-Director, Johns Hopkins Memory and Alzheimer's Treatment Center and; Dr. Mfon E. Umoh, Assistant Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins University School of Medicine, as they discuss Evaluation of Cognition and Cognitive Disorder.

To view a transcript click here then select the transcript tab.

Read moreCollapse

Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence Is Not Inclusive

Season 1 · Episode 7

Wednesday, October 15, 2025 • Duration 20:07

Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Sharon Brangman, Professor of Geriatric Medicine, Chief of the Department of Geriatrics, Director of the Center of Excellence for Alzheimer's Disease (CEAD), Director of University Geriatricians, and Chair of the Department of Geriatrics at SUNY Upstate University Hospital; and Dr. Alejandra Sanchez Lopez, Assistant Clinical Professor of Neurology and Geriatric Medicine at UCLA, as they discuss Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence is Not Inclusive.

To view a transcript click here then select the transcript tab.

Read moreCollapse